18
LONG TERM CARE TODAY   Fall/Winter 2026
A
s with any instrument in the medical field, artificial 
intelligence (AI) can be a life-changing tool in 
the right hands. Recently, that potential was 
demonstrated during a wound care evaluation involving 
peopleCare Communities, the Ontario Bioscience 
Innovation Organization (OBIO) and Skinopathy.
Skinopathy, an Ontario-based health technology company, 
has developed an AI-driven platform to support skin and 
wound assessment, treatment planning, and clinical 
documentation. Using an app on a mobile device, 
nurses photograph a wound and upload the image to 
the platform. It then measures and analyzes the wound, 
identifies tissue types, recommends evidence-based 
treatment options, documents the assessment, and tracks 
healing over time – all while leaving the final clinical 
decision to the care team.
"We call it ‘glass box’ technology in that it tells you exactly 
what we see, and why it leads to a decision,” says Keith 
Loo, Skinopathy’s CEO and Co-Founder. “Think of it as an 
advanced stethoscope or just another tool in your tool 
belt. We're not trying to replace your judgment; we're just 
trying to show you objective facts and what that can  
lead to."
Discovering Skinopathy 
Skinopathy Wounds was originally developed to help 
clinicians and patients detect skin cancer using affordable, 
AI-powered technology. As its capabilities and reputation 
grew, burn units and emergency responders began using 
the same technology to gauge the severity of burns.
It wasn't long before the long-term care sector took 
notice. Jenn Killing, Vice President of Quality, Research 
and Strategic Partnerships at peopleCare Communities, 
first crossed paths with Loo and his team at a health care 
innovation showcase and quickly recognized Skinopathy’s 
potential in a long-term care environment. 
"When I saw the demonstration, I realized this type of 
technology could be game-changing for our nurses,” 
she says. “It could provide better guidance, help us track 
progress, support care planning, and allow us to connect 
with specialists digitally, which is one of the biggest 
challenges we face in long-term care."
As residents become older and more medically complex, 
consistent skin and wound assessments have become 
increasingly difficult. Variations between care team 
Applying AI to 
wound care
Inside peopleCare's Skinopathy 
Wounds evaluation 
members, lighting conditions and assessment times can all 
affect the accuracy and consistency of assessments, and 
these inconsistencies can hinder timely and  
effective responses.
Recognizing the potential for addressing these issues, 
Killing and her team at peopleCare partnered with 
Skinopathy for a year-long initiative to explore whether 
its AI product could help clinicians deliver faster, 
more consistent wound assessments while reducing 
documentation burdens.
Funding for the project was provided through a partnership 
with OBIO’s Life Sciences Critical Technologies & 
Commercialization Centre of Excellence, an organization 
that connects health technology innovators with health 
care providers to evaluate and scale promising new 
solutions. "In a resource-strapped sector such as long-
term care, this type of funding for innovation is invaluable,” 
Killing says.
Bringing Skinopathy home 
peopleCare began evaluating the AI tech in November 
2024 with Mazhar Muhammed, an experienced registered 
nurse with the organization, as its clinical lead. Over 
the next 12 months, Muhammed conducted wound 
assessments using both Skinopathy Wounds and 
peopleCare's existing skin and wound care platform, 
comparing results along the way and collecting feedback 
to help Loo and his team refine the platform for use in a 
long-term care environment.
Initially, Muhammed recalls, there was some hesitation 
because skin and wound care process and documentation 
is subject to rigorous Ministry of Long-Term Care 
requirements.  Those concerns eased as the platform 
WOUND CARE

View this content as a flipbook by clicking here.